SEC Settles Charges With 2 UBS Advisory Firms
The SEC has announced that two UBS advisory firms have agreed to settle charges stemming from their roles in failing to disclose a change in investment strategy by UBS Willow Fund.
The SEC has announced that two UBS advisory firms have agreed to settle charges stemming from their roles in failing to disclose a change in investment strategy by UBS Willow Fund.
Corbus Pharmaceuticals announced that the FDA has designated as a Fast Track development program and granted Orphan Drug Designation to the its investigational new drug Resunab.
The SEC recently published a report that provides private fund industry statistics and trends, reflecting aggregated data reported by private fund advisers.
Merus has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Kinder Morgan has announced that it will acquire 15 refined products terminals and associated U.S. infrastructure from a division of BP in a transaction valued at about $350 million.
Forget about the old Hewlett-Packard; the "when issued" shares of the break-up companies have finally arrived.
Yum Brands will spin off its Yum! China operations into a separately traded public company that will have exclusive rights to Yum's three top franchises.
The Fresh Market has confirmed some light news and rumors from the prior week, although perhaps not in the exact manner that was initially reported.
Energy Recovery took off like a rocket in Tuesday’s session following news of a new license agreement with Schlumberger.
Each week we cover the new value calls from the analysts at Jefferies, and increasingly, some of the calls may look surprising.
courtesy of Walt Disney Co.Walt Disney Co. (NYSE: DIS) has been one of the greatest growth stocks of the Dow Jones Industrial Average. With franchises from Marvel to Frozen to Star Wars, and with…
The U.S. Census Bureau and the Department of Housing and Urban Development reported Tuesday morning that new housing starts in September rose.
Boeing is expected to report its third-quarter results before markets open Wednesday morning.
Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also thinks third-quarter earnings beats could highlight the risk of not owning biotech now.
United Technologies released mixed third-quarter earnings report before the markets opened on Tuesday.